HMFG1 ANTIGEN - A NEW MARKER FOR CARCINOMATOUS MENINGITIS

被引：16
|
作者：
MOSELEY, RP
OGE, K
SHAFQAT, S
MOSELEY, CM
SULLIVAN, NM
BADLEY, RA
BURCHELL, J
TAYLORPAPADIMITRIOU, J
COAKHAM, HB
机构：
[1] FRENCHAY HOSP,DEPT NEUROSURG,BRISTOL BS16 1LE,AVON,ENGLAND
[2] UNILEVER RES LABS,COLWORTH LAB,SHARNBROOK MK44 1LQ,BEDS,ENGLAND
[3] IMPERIAL CANC RES FUND,DEPT EPITHELICAL CELL BIOL,LONDON WC2A 3PX,ENGLAND
来源：
INTERNATIONAL JOURNAL OF CANCER | 1989年 / 44卷 / 03期
关键词：
D O I：
10.1002/ijc.2910440310
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：440 / 444
页数：5
相关论文
共 50 条
  • [1] CARCINOMATOUS MENINGITIS - ANTIBODY-GUIDED THERAPY WITH I-131 HMFG1
    MOSELEY, RP
    BENJAMIN, JC
    ASHPOLE, RD
    SULLIVAN, NM
    BULLIMORE, JA
    COAKHAM, HB
    KEMSHEAD, JT
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1991, 54 (03): : 260 - 265
  • [2] CYTOPLASMIC REACTIVITY WITH MONOCLONAL-ANTIBODY HMFG1 AS MARKER OF CERVICAL GLANDULAR ATYPIA
    BROWN, LJR
    GRIFFIN, NR
    WELLS, M
    JOURNAL OF PATHOLOGY, 1986, 149 (03): : A239 - A240
  • [3] CYTOPLASMIC REACTIVITY WITH THE MONOCLONAL-ANTIBODY HMFG1 AS A MARKER OF CERVICAL GLANDULAR ATYPIA
    BROWN, LJR
    GRIFFIN, NR
    WELLS, M
    JOURNAL OF PATHOLOGY, 1987, 151 (03): : 203 - &
  • [4] Trials of monoclonal antibody HMFG1 in ovarian cancer
    Nicholson, S
    Snary, D
    Taylor-Papadimitriou, J
    Thomas, H
    ANNALS OF ONCOLOGY, 1998, 9 : 85 - 85
  • [5] Human milk fat globule antigen 1 (HMFG1) expression in prostatic carcinoma and immunotargeting with a radiolabelled monoclonal anti-HMFG1 antibody
    Ljung, G
    Lennernäs, B
    Nordgren, H
    Holmberg, A
    Westlin, JE
    Nilsson, S
    Edgren, M
    ANTICANCER RESEARCH, 2000, 20 (04) : 2321 - 2324
  • [6] IMMUNOCYTOCHEMICAL INVESTIGATION OF THYROID LESIONS WITH THE MONOCLONAL-ANTIBODIES HMFG1 AND HMFG2
    KANDARAKI, C
    VENETI, S
    BEIS, I
    TINIAKOS, G
    AUGOYSTATOS, P
    EPENETOS, A
    SCARLOS, D
    PATHOLOGY RESEARCH AND PRACTICE, 1985, 180 (03) : 282 - 282
  • [7] A NEW IMMUNOASSAY USING MONOCLONAL-ANTIBODIES HMFG1 AND HMFG2 TOGETHER WITH AN EXISTING MARKER CA125 FOR THE SEROLOGICAL DETECTION AND MANAGEMENT OF EPITHELIAL OVARIAN-CANCER
    DHOKIA, B
    CANNEY, PA
    PECTASIDES, D
    MUNRO, AJ
    MOORE, M
    WILKINSON, PM
    SELF, C
    EPENETOS, AA
    BRITISH JOURNAL OF CANCER, 1986, 54 (06) : 891 - 895
  • [8] THE PROGNOSTIC VALUE OF THE MONOCLONAL-ANTIBODIES HMFG1 AND HMFG2 IN BREAST-CANCER
    BERRY, N
    JONES, DB
    SMALLWOOD, J
    TAYLOR, I
    KIRKHAM, N
    TAYLORPAPADIMITRIOU, J
    BRITISH JOURNAL OF CANCER, 1985, 51 (02) : 179 - 186
  • [9] THE PROGNOSTIC VALUE OF HMFG1 AND HMFG2 MONOCLONAL-ANTIBODIES IN BREAST-CANCER
    BERRY, N
    JONES, DB
    SMALLWOOD, J
    TAYLOR, I
    KIRKHAM, N
    TAYLORPAPADIMITRIOU, J
    BRITISH JOURNAL OF SURGERY, 1984, 71 (05) : 390 - 390
  • [10] A phase I trial of idiotypic vaccination with HMFG1 in ovarian cancer
    Steve Nicholson
    C. C. Bomphray
    H. Thomas
    A. McIndoe
    D. Barton
    M. Gore
    Andrew J. T. George
    Cancer Immunology, Immunotherapy, 2004, 53 : 809 - 816
12345